bioRxivNeurosciencePreprint
Divergent amyloid trajectories distinguish normal aging from Alzheimer's disease progression
Mingzhao TongiD, Tianchuan Gao, Yurika Upadhyaya, Kwangsik T. NhoiD, Shiaofen FangiD, Andrew J. SaykiniD, Jingwen YaniD, Alzheimer’s Disease Neuroimaging Initiative
Abstract
Aging is the greatest risk factor for Alzheimer's disease (AD), yet how and when AD-related pathological progression diverges from aging remains poorly understood. This distinction is particularly difficult at early stages, when clinically and biomarker-defined populations contain individuals following fundamentally different trajectories. Here, we model AD progression as a deviation from aging using longitudinal amyloid PET and a self-supervised trajectory-learning framework. In ADNI, the learned trajectory revealed a shared early path that bifurcated into an aging branch and an AD-related branch. The two branches showed distinct profiles in amyloid burden, cognitive decline, risk of progression to AD dementia, and genetic risk. Unseen participants from the independent NACC cohort were projected onto the trajectory without retraining, further reproducing key branch-specific biological and genetic patterns. Together, the bifurcating trajectory provides a biologically grounded framework for resolving early-stage heterogeneity and enabling risk stratification beyond binary amyloid status.
- organism: human
- assay: bulk RNA-seq
- research focus: trajectory inference
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Learning a Continuous Progression Trajectory of Amyloid in Alzheimer's disease
Mingzhao Tong, Fahad Mehfooz, … the Frontotemporal Lobar Degeneration Neuroimaging Initiative·bioRxiv·Feb 18, 2026
- Amyloid duration is associated with preclinical cognitive decline and tau PET
Rebecca L. Koscik, Tobey J. Betthauser, … Sterling C. Johnson·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Jan 1, 2020
- TIMELINE OF BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE ACROSS THE ENTIRE LIFESPAN
Pierrick Coupé A, José V. Manjón, … Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·Dec 7, 2017
- Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease
Monireh Taimouri, Vikram Ravindra·bioRxiv·Jun 24, 2026
- Genetic Associations with Temporal Modeling of Alzheimer's Disease Progression Supports a Novel Paradigm for Disease Risk
Daniel M. Jordan, Eli Kritzer, … Noam D. Beckmann·medRxiv·Jul 10, 2026
- Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration
Alexei Taylor, Fengqing Zhang, … the Alzheimer’s Disease Neuroimaging Initiative·NeuroImagePeer-reviewed·Sep 9, 2022